ListedMainboardKIMS

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited is a mainboard IPO raising ₹2,143 Cr at ₹815 – ₹825 a share. It listed on 28 Jun 2021. We do not have a current price for it yet. It was subscribed 3.86× in total.

825
Issue price
Price now
Since issue price
28 Jun 2021
Listed on
3.86×Subscribed (final) · all exchanges

3.9 times more demand than shares on offer

populated partly populated we hold nothing here — the tab says why

How its cohort has done

50 mainboard issues listed in 2021 that we can price today. This is the group this issue belongs to.

+46.0%
Median return since issue price
38%
Now trading below their issue price

Neither figure is a forecast for this issue — they describe what happened to comparable issues. Full cohort analytics →

How the book finished

The category split is the number worth reading, not the total.

QIB5.26×
Non-institutional1.89×
Retail2.89×

QIB: 5.26× their allocation. Non-institutional: 1.89×.

See the full split, sub-category by sub-category →

What we hold for this issue

Stated up front on every issue, so a sparse page reads as a fact about the source rather than a broken one.

Category split — who bidQIB, non-institutional and retail, with sub-splits
How demand built over timeNo subscription figure was published
Price-point demand curveLive only — NSE stops serving this once bidding closes
Lead managers and registrar4 banks
Official documents4 documents
Performance since listingWe do not have a price for this company yet

What happens when

16 Jun 2021Bidding opens
18 Jun 2021Bidding closes
23 Jun 2021Allotment finalised — you find out what you got
24 Jun 2021Money refunded to unsuccessful bidders
28 Jun 2021Shares list and start trading

Track Krishna Institute of Medical Sciences Limited

Results, orders, board decisions and every other filing — summarised and sent to your WhatsApp the minute they are out.

Get free alerts

Figures are as published by the exchanges and the issuer’s prospectus. MarketPing publishes facts, comparisons and history only — nothing here is a recommendation to apply to this issue, and we do not publish grey market premium.